⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Nadolol

نادولول

⚠ Unverified

❤️ Cardiovascular SystemNon-selective beta-blocker

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Safety not established 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA201893 ATC C07AA12

Market / country: 🇺🇸 USA

Corgard (US)

🧮 Dose calculator

Disease / regimen

Angina pectoris · Regimen source: FDA Nadolol · Dosage and Administration

• Increase by 40–80 mg every 3–7 days. Abrupt cessation may exacerbate angina and MI. FDA Nadolol · Dosage and Administration FDA Nadolol · Warnings

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Bronchial asthma; sinus bradycardia and greater than first-degree block; cardiogenic shock; overt cardiac failure. FDA Nadolol · Contraindications

Warnings

• Abrupt withdrawal — exacerbated angina and occasionally MI; taper gradually. FDA Nadolol · Warnings

Renal adjustment

• eGFR < 50: Renal failure: extend the dosing interval by CrCl (per label). FDA Nadolol · Dosage and Administration

Formulations

20 mg tablet (scored) — tablet 🇺🇸 USA FDA Nadolol · How Supplied
40 mg tablet (scored) — tablet 🇺🇸 USA FDA Nadolol · How Supplied
80 mg tablet (scored) — tablet 🇺🇸 USA FDA Nadolol · How Supplied

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Nadolol · PREGNANCY
“Nadolol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Nadolol · NURSING MOTHERS
“Nadolol is excreted in human milk.”
👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Nadolol · PEDIATRIC USE
“Safety and effectiveness in pediatric patients have not been established.”
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA201893
DailyMed (FDA label)FDA Nadolol
MedlinePlus (NIH)Nadolol
WHO ATC/DDDC07AA12
Darooyab (Iran)Nadolol

🇮🇷 Registered in Iran Darooyab · G-1781/Nadolol

Dosage forms with Iranian generic codes, per Darooyab.

01604 · NADOLOL 80 MG TAB · قرص نادولول ۸۰ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Nadolol · How Supplied FDA Nadolol · Dosage and Administration FDA Nadolol · Warnings FDA Nadolol · Contraindications FDA Nadolol · SPL approval / marketing category FDA Nadolol · PREGNANCY FDA Nadolol · NURSING MOTHERS FDA Nadolol · PEDIATRIC USE
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1781/Nadolol
Clinical review⚠ Unverified